Evidence map›Paper›PMID 41484727›Full record

ArticleApplied biochemistry and biotechnology2026

Adiponectin Promotes SHBG Expression in Trophoblast Cells and Improves Insulin Signaling in Streptozotocin-Induced Gestational Diabetes Mellitus Rats.

Yijie Cheng, Shangling Lv, Ronghui Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yijie ChengDepartment of Obstetrics, Yantaishan Hospital, Yantai, No.10087, Keji Avenue, Laishan District, 264003, China.
Shangling LvDepartment of Obstetrics, Yantaishan Hospital, Yantai, No.10087, Keji Avenue, Laishan District, 264003, China.
Ronghui LiuDepartment of Obstetrics, Yantaishan Hospital, Yantai, No.10087, Keji Avenue, Laishan District, 264003, China. ytsytsyyck6@163.com.ORCID http://orcid.org/0009-0008-0535-4023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective This study aimed to explore the possible mechanism of adiponectin on the insulin signaling in streptozotocin (STZ)-induced gestational diabetes mellitus (GDM) rats. Methods The GDM rats were induced by injection of 40 mg/kg STZ, and then orally treated with adiponectin (5, 10, 20 mg/kg) every day from gestation day (GD)7 to GD20. The body weight and fasting blood glucose (FBG) were observed every 3 days from GD9 to GD18. Meanwhile, the insulin tolerance test (ITT), homeostasis model assessment insulin resistance (HOMA-IR), and adiponectin expression were observed in rats. Moreover, the insulin signaling-related factors, sex hormone-binding globulin (SHBG), PPAR-α, phospho-AMPK alpha, glucose transporter-3 (GLUT3), and phospho-insulin receptor substrate-1 (p-IRS1) in placental tissues were measured in rats. In vitro, HTR-8-Svneo cells were induced by 30 mM glucose and then treated with adiponectin (50, 100, 200 ng/mL) to observe the changes in cell viability, SHBG expression, and the insulin signaling-related factors. Moreover, silencing or overexpression of SHBG was achieved via transfection with siRNA or pEX-4 SHBG, respectively. The effects of SHBG on the insulin signaling-related factors were observed in cells. Results Adiponectin treatment significantly improved the STZ-induced decrease in body weight, increase in the FBG, ITT, and HOMA-IR with increasing doses. Specifically, adiponectin treatment upregulated the SHBG expression and the insulin signaling-related factors (PPAR-α, p-AMPK, GLUT3, and p-IRS1) in the placental tissues of GDM rats with increasing doses. In line with the results of animal experiments, adiponectin treatment alleviated the high glucose-induced decrease in cell viability, SHBG expression, and the levels of GLUT3 and p-IRS1 in HTR-8-Svneo cells with increasing doses. Moreover, the levels of GLUT3 and p-IRS1 were regulated by the SHBG expression. SHBG silencing weakened the effect of adiponectin in improving the levels of GLUT3 and p-IRS in the high-glucose-induced cells. Conclusion The study showed that adiponectin upregulated the SHBG expression and improved the insulin signaling in STZ-induced GDM rats, as well as adiponectin upregulated the insulin signaling-related factors via SHBG in high-glucose-induced trophoblast cells. This study suggests that adiponectin may be a potential therapeutic target in GDM.

Indexed as

AdiponectinDiabetes, GestationalDiabetes Mellitus, ExperimentalInsulinSex Hormone-Binding GlobulinSignal TransductionTrophoblastsAnimalsCell LineFemaleGlucose Transporter Type 3HumansInsulin Receptor Substrate ProteinsPregnancyRatsRats, Sprague-DawleyAdiponectinGlucose Transporter Type 3InsulinInsulin Receptor Substrate ProteinsSex Hormone-Binding GlobulinStreptozocinAdiponectinGestational diabetes mellitusHTR-8-Svneo cellSex hormone-binding globulinStreptozotocin

Identifiers

PMID41484727

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.